Novavax, Inc. ( NVAX) - Key Metrics
NVAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.34 | -$0.32 | -$0.46 | -$0.45 |
| 2026Q1 | $0.85 | -$0.06 | -$0.20 | -$0.21 |
| 2025Q4 | $0.91 | $0.11 | -$0.24 | -$0.26 |
| 2025Q3 | $0.43 | -$1.25 | $0.66 | $0.65 |
| 2025Q2 | $1.48 | $0.66 | -$0.79 | -$0.79 |
NVAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.36 |
| 2026Q1 | 0% | -33.92 |
| 2025Q4 | 0% | 15.27 |
| 2025Q3 | 0% | -1.73 |
| 2025Q2 | 0% | 2.39 |
NVAX
Price: $8.05
52 week price:
Earnings Per Share: -1.53 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6.6 million
Ebitda: -37.6 millionMarket Capitalization: 1.3 billion